| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |